Inulin Alleviates Atherosclerosis Through Improving Lipid Metabolism, Inflammation, and Gut Microbiota in ApoE-knockout Mice: the Short-chain is More Efficacious

Overview

Journal Front Pharmacol

Date 2024 Oct 25

PMID 39449970

Authors

Kun Zhang

Yu Zeng

Jiawei Li

Yingchun Huang

Nan Zhang

Yue Gong

Kaihu Xiao

Jian Chen

Tiantian Chen

Haomin Qiu

Sisi Lei

Fei Yan

Chunhui Lang

Xudong Duan

Xianwen Dong

Affiliations

Soon will be listed here.

Abstract

Introduction: Atherosclerosis (AS) is considered the underlying cause of many diseases, particularly cardiovascular and cerebrovascular diseases. Inulin, a type of fructan, has shown potential in improving atherosclerosis, although there are conflicting findings. It is hypothesized that the polymerization degree of inulin may largely influence its therapeutic effectiveness. Therefore, this study aimed to investigate the effects and mechanisms of short-chain and long-chain inulin in AS.

Methods: ApoE mice fed a high fat diet (HFD) were used to establish an atherosclerosis model. These mice received daily oral administration of either short-chain or long-chain inulin for 12 weeks. Plasma lipid metabolism-related indices were measured using biochemical analysis, and plasma immunological indices were analyzed via ELISA. The aorta, aortic root regions, liver tissue, adipose tissue, and colon tissue were examined through various staining techniques, including ORO staining, hematoxylin and eosin staining, Alcian blue staining, and immunofluorescent or immunohistochemical assays. Microbiome analysis was conducted in the cecal content.

Results: The results indicated that both short-chain and long-chain inulin substantially reduced the formation of atherosclerotic plaques. Inulin also improved plasma lipid concentrations and hepatic lipid metabolism, and partially alleviated both localized (atherosclerotic lesions) and systemic inflammation. Short-chain inulin was more effective than long-chain inulin in reducing atherosclerotic plaques formation, enhancing lipid metabolism and reducing inflammation. Additionally, both types of inulin showed similar effectiveness in enhancing intestinal epithelial barrier integrity, gut microbiota composition and functionality.

Conclusion: These findings suggest that inulin has a protective role against atherosclerosis by enhancing lipid metabolism, reducing inflammation, and improving intestinal barrier and gut microbiota. As a dietary intervention, short-chain inulin is more effective than long-chain inulin, offering clinical implications for using inulin as a therapeutic agent for atherosclerosis.

References

Lewis C, Taylor W . Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am J Physiol Heart Circ Physiol. 2020; 319(6):H1227-H1233. PMC: 7792706. DOI: 10.1152/ajpheart.00612.2020. View

Lai S, Mazzaferro S, Muscaritoli M, Mastroluca D, Testorio M, Perrotta A . Prebiotic Therapy with Inulin Associated with Low Protein Diet in Chronic Kidney Disease Patients: Evaluation of Nutritional, Cardiovascular and Psychocognitive Parameters. Toxins (Basel). 2020; 12(6). PMC: 7354587. DOI: 10.3390/toxins12060381. View

Dong X . Sirtuin 6-A Key Regulator of Hepatic Lipid Metabolism and Liver Health. Cells. 2023; 12(4). PMC: 9954390. DOI: 10.3390/cells12040663. View

Wu Z, Du Z, Tian Y, Liu M, Zhu K, Zhao Y . Inulin accelerates weight loss in obese mice by regulating gut microbiota and serum metabolites. Front Nutr. 2022; 9:980382. PMC: 9554005. DOI: 10.3389/fnut.2022.980382. View

Wang B, Kong Q, Li X, Zhao J, Zhang H, Chen W . A High-Fat Diet Increases Gut Microbiota Biodiversity and Energy Expenditure Due to Nutrient Difference. Nutrients. 2020; 12(10). PMC: 7589760. DOI: 10.3390/nu12103197. View

Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P . The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients. 2020; 12(5). PMC: 7285218. DOI: 10.3390/nu12051474. View

Lin Z, Zhang B, Liu X, Jin R, Zhu W . Effects of chicory inulin on serum metabolites of uric acid, lipids, glucose, and abdominal fat deposition in quails induced by purine-rich diets. J Med Food. 2014; 17(11):1214-21. DOI: 10.1089/jmf.2013.2991. View

Lawson C, Wolf S . ICAM-1 signaling in endothelial cells. Pharmacol Rep. 2009; 61(1):22-32. DOI: 10.1016/s1734-1140(09)70004-0. View

Oram J, Vaughan A . ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res. 2006; 99(10):1031-43. DOI: 10.1161/01.RES.0000250171.54048.5c. View

10.

Yang Z, Su H, Lv Y, Tao H, Jiang Y, Ni Z . Inulin intervention attenuates hepatic steatosis in rats via modulating gut microbiota and maintaining intestinal barrier function. Food Res Int. 2023; 163:112309. DOI: 10.1016/j.foodres.2022.112309. View

11.

Grainger D, Reckless J, McKilligin E . Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol. 2004; 173(10):6366-75. DOI: 10.4049/jimmunol.173.10.6366. View

12.

Hoving L, de Vries M, de Jong R, Katiraei S, Pronk A, Quax P . The Prebiotic Inulin Aggravates Accelerated Atherosclerosis in Hypercholesterolemic APOE*3-Leiden Mice. Nutrients. 2018; 10(2). PMC: 5852748. DOI: 10.3390/nu10020172. View

13.

Rault-Nania M, Gueux E, Demougeot C, Demigne C, Rock E, Mazur A . Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice. Br J Nutr. 2006; 96(5):840-4. DOI: 10.1017/bjn20061913. View

14.

Hoving L, Katiraei S, Pronk A, Heijink M, Vonk K, Amghar-El Bouazzaoui F . The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden.CETP mice. Sci Rep. 2018; 8(1):16515. PMC: 6224586. DOI: 10.1038/s41598-018-34970-y. View

15.

Luo L, Luo J, Cai Y, Fu M, Li W, Shi L . Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy. Pharmacol Res. 2022; 183:106367. DOI: 10.1016/j.phrs.2022.106367. View

16.

Wan X, Guo H, Liang Y, Zhou C, Liu Z, Li K . The physiological functions and pharmaceutical applications of inulin: A review. Carbohydr Polym. 2020; 246:116589. DOI: 10.1016/j.carbpol.2020.116589. View

17.

Wu M, Dong B, Cao A, Li H, Liu J . Delineation of molecular pathways that regulate hepatic PCSK9 and LDL receptor expression during fasting in normolipidemic hamsters. Atherosclerosis. 2012; 224(2):401-10. PMC: 4528917. DOI: 10.1016/j.atherosclerosis.2012.08.012. View

18.

Chen B, Shi Y, Zhang K, Chang Y, Fu P, Liu P . Inulin reduces liver triacylglycerol by increasing lipid droplet lipolysis in fat-loaded mice. Food Res Int. 2023; 163:112226. DOI: 10.1016/j.foodres.2022.112226. View

19.

Akram W, Garud N, Joshi R . Role of inulin as prebiotics on inflammatory bowel disease. Drug Discov Ther. 2019; 13(1):1-8. DOI: 10.5582/ddt.2019.01000. View

20.

Zhao Q, Liu Z, Zhu Y, Wang H, Dai Z, Yang X . Cooked Adzuki Bean Reduces High-Fat Diet-Induced Body Weight Gain, Ameliorates Inflammation, and Modulates Intestinal Homeostasis in Mice. Front Nutr. 2022; 9:918696. PMC: 9241564. DOI: 10.3389/fnut.2022.918696. View